RECORD // Company

Evofem Biosciences, Inc.

Formerly: Neothetics, Inc.

Built 2026-11-22T05:19:40Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
SEC EDGAR (1)
Records under a former name (1)

The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.

Matched by name only, not merged (5)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • EVOFEM BIOSCIENCES INC · East licences · same registered legal name as 'Evofem Biosciences, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Evofem Biosciences, Inc. · East licences · same registered legal name as 'Evofem Biosciences, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EVOFEM BIOSCIENCES, INC. · Epa echo · same registered legal name as 'Evofem Biosciences, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EVOFEM BIOSCIENCES, INC. · Ny corps · same registered legal name as 'Evofem Biosciences, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • EVOFEM BIOSCIENCES, INC. · USAspending · same registered legal name as 'Evofem Biosciences, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-13 · accession 0001493152-26-051802

ItemValuePeriodFormFiledAccessionReport
Revenue$4,628,0003 months ended 2026-09-3010-Q2026-11-130001493152-26-0518022026-11-22 05:19 UTCReport an error
Net income (loss)$1,004,0003 months ended 2026-09-3010-Q2026-11-130001493152-26-0518022026-11-22 05:19 UTCReport an error
Interest expense$1,922,0009 months ended 2026-09-3010-Q2026-11-130001493152-26-0518022026-11-22 05:19 UTCReport an error
Cash and cash equivalents$317,000at 2026-09-3010-Q2026-11-130001493152-26-0518022026-11-22 05:19 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001618835
Ticker
EVFM
EIN
208527075
CUSIP
30048L302
Record ID
sx:sec:0001618835

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

20 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-18SEC EDGAR company profile2026-11-22 05:19 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-18SEC EDGAR company profile2026-11-22 05:19 UTCReport an error
State of incorporationDE2026-11-18SEC EDGAR company profile2026-11-22 05:19 UTCReport an error
Fiscal year end (MMDD)12312026-11-18SEC EDGAR company profile2026-11-22 05:19 UTCReport an error
Business address12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 921302026-11-18SEC EDGAR company profile2026-11-22 05:19 UTCReport an error
ExchangesOTC2026-11-18SEC EDGAR company profile2026-11-22 05:19 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$20,183,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-22 05:19 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$391,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 05:19 UTCReport an error
Total assets (at 2025-12-31)$20,274,0002025-12-3110-K, XBRL Assets2026-11-22 05:19 UTCReport an error
Stockholders' equity (at 2025-12-31)$-74,336,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 05:19 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$578,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 05:19 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-1,992,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 05:19 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$5,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 05:19 UTCReport an error
Operating lease liabilities (at 2025-12-31)$182,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 05:19 UTCReport an error
Form D total offering amount (D filed 2025-07-02)$925,0002025-07-02D2026-11-22 05:19 UTCReport an error
Form D total amount sold (D filed 2025-07-02)$925,0002025-07-02D2026-11-22 05:19 UTCReport an error
Form D industry groupBiotechnology2025-07-02D2026-11-22 05:19 UTCReport an error
Form D revenue rangeDecline to Disclose2025-07-02D2026-11-22 05:19 UTCReport an error
Form D date of first sale2025-06-262025-07-02D2026-11-22 05:19 UTCReport an error
8-K Item 1.01, Entry into (filed 2026-09-23)a Material Definitive Agreement. On September 17, 2026, Evofem Biosciences, Inc. (the “Company”) entered into a Manufacturing Agreement with Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited, a Hong Kong company organized and existing under the laws of Hong Kong and Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited., a company organized under the laws of the People’s Republic of China (together, “Zhaoke”), pursuant to which Zhaoke agreed to become a manufacturer and supplier of PHEXX® (lactic acid, citric acid, and potassium bitartrate). The foregoing summary of the Manufacturing Agreement does not purport to be complete and is qualified in its entirety by reference to the…2026-09-23SEC EDGAR 8-K 0001493152-26-043919 (text as filed, excerpt)2026-11-22 05:19 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.